Lantheus Holdings (LNTH) Reiterated at Market Outperform by Citizens: Stock Inexpensive

Citizens analyst David Turkaly reiterated a Market Outperform rating and $85.00 price target on Lantheus Holdings (NASDAQ: LNTH).

The analyst commented, "We remain encouraged about the development of some royalty opportunities, including Flyrcado (cardiac perfusion imaging agent partnered with GE) and Pylclari (or PYLARIFY in Europe partnered with Curium), both of which could potentially start to contribute at a meaningful clip in the medium term. Yet we model zero contribution from all new therapeutic and diagnostic opportunities through 2027, and we still think the stock looks inexpensive versus similar-sized, high-growth peers. Our $85 price target is based on a 14x-15x multiple applied to our 2027E EPS of $5.70."

For an analyst ratings summary and ratings history on Lantheus Holdings click here. For more ratings news on Lantheus Holdings click here.

Shares of Lantheus Holdings closed at $72.56 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
• Full Circle Lithium closes $5.14M private placement